Jacob A. Canick, Ph.D.

Director, Division of Prenatal and Special Testingl
Professor of Pathology
Jcanick@wrhri.org
T: 401 453-7654
F: 401 276-7882

Women and Infants Hospital of Rhode Island
70 Elm St
Providence, RI 02903

Medical Education/Graduate Education:

Ph.D. University of Rhode Island, 1972: Biochemistry

Fellowship:

Research Fellow, Harvard Medical School 1972-1975

Board Certification:

State of RI: Clinical Laboratory Scientist (LS 00983)
State of NY: Cert. Of Qualification Lab Director (CANIJ1)

Research Interests:

Prenatal Screening, Hormones of Pregnancy, Reprod. Endocrinology.

Current Approved Research Grants:

R01 HD 38652: First and Second Trimester Evaluation of Risk of Aneuploidy (FASTER)

Most Recent Significant Publications:

Canick, JA, MacRae, AR 2005. Second trimester serum markers. In: Seminars in Perinatology. Vol. 29(4), Reddy, UM, Mennuti, MT, eds. Elsevier pp 203-208.

MacRae, AR, Canick, JA 2004. Maternal prenatal screen for fetal defects. In: Current Clinical Pathology: Handbook of Clinical Laboratory Testing During Pregnancy. Gronowski, AM, ed. Humana Press, pp 71-137.

Malone, FD, Canick, JA, Ball, RH, Nyberg, DA, Comstock, CH, Bukowski, R, Berkowitz, RL, Gross, SJ, Dugoff, L, Craigo, SD, Timor-Tritsch, IE, Carr, SR, Wolfe, HM, Dukes, K, Bianchi, DW, Rudnicka, AR, Hackshaw, AK, Lambert-Messerlian, G, Wald, NJ, D'Alton, ME 2005. First trimester or second trimester screening or both for Down's syndrome. N Eng J Med 353, 2001-2001.